Zobrazeno 1 - 10
of 28
pro vyhledávání: '"He Nan Wang"'
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
BackgroundCurrently, there is no standard treatment for relapsed/refractory NK/T-cell lymphoma (NKTCL). Liposomal mitoxantrone (Lipo-MIT) showed good anti-tumor effect in patients with NKTCL, breaking the limitation of natural resistance of NKTCL to
Externí odkaz:
https://doaj.org/article/010352c205fc4b03b5962a494d7d629f
Autor:
He‐nan Wang, Jing Yang, De‐Huan Xie, Zhigang Liang, Yang Wang, Rui‐ying Fu, Xindi Liu, Zhong‐jun Xia, Guangshuai Jia, Liang Wang
Publikováno v:
Clinical and Translational Medicine, Vol 11, Iss 12, Pp n/a-n/a (2021)
Externí odkaz:
https://doaj.org/article/1032056313f34d77b1f6c5b9b561f0c2
Publikováno v:
工程科学学报, Vol 41, Iss 11, Pp 1444-1449 (2019)
Al−Li alloys have the advantage of low density, high strength and toughness, and low corrosion fatigue rate. This combination of properties has led to their use in aerospace. Al3Li（δ′）phase is one of main strengthening phases of Al−Li allo
Externí odkaz:
https://doaj.org/article/fe185517eb9e40b595df05fec4e0fb5b
Publikováno v:
Journal of Immunology Research, Vol 2021 (2021)
Background. Diffuse large B cell lymphoma (DLBCL) is a life-threatening malignant tumor characterized by heterogeneous clinical, phenotypic, and molecular manifestations. Given the association between immunity and tumors, identifying a suitable immun
Externí odkaz:
https://doaj.org/article/00816f5233624286aa5ce597235bd7ac
Publikováno v:
Journal of Cancer
Immune checkpoint blockade has vastly changed the landscape of cancer treatment and showed a promising prognosis for cancer patients. However, there is still a large portion of patients who have no response to this therapy. Therefore, it's essential
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::88dc532f79e9f7dc189920da27d80eff
http://europepmc.org/articles/PMC8771507
http://europepmc.org/articles/PMC8771507
Publikováno v:
Journal of Immunology Research
Journal of Immunology Research, Vol 2021 (2021)
Journal of Immunology Research, Vol 2021 (2021)
Background. Diffuse large B cell lymphoma (DLBCL) is a life-threatening malignant tumor characterized by heterogeneous clinical, phenotypic, and molecular manifestations. Given the association between immunity and tumors, identifying a suitable immun
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7089028e462c89917be4be8f3931da60
https://doi.org/10.1155/2021/5564568
https://doi.org/10.1155/2021/5564568
Autor:
He-nan Wang, Liqiang Wei, Jingwen Wang, Xin-di Liu, Rui-ying Fu, Yingshi Piao, Jing Yang, Liang Wang, Luo Zhang
Publikováno v:
Theranostics
Background: Asparaginase (ASP) is the cornerstone drug in the treatment of extranodal NK/T-cell lymphoma (ENKTCL), and the mechanisms of resistance to ASP remain largely unknown. Long non-coding RNAs play important roles in chemotherapy resistance in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ee32c1d733c34b889342c8cbcf702702
https://doi.org/10.7150/thno.46655
https://doi.org/10.7150/thno.46655
Publikováno v:
Aging Pathobiology and Therapeutics. 2:109-113
XPO1 is a transporter receptor protein that transports leucine-rich proteins from the nucleus into the cytoplasm through the nuclear pore complex. In hematologic malignancies, XPO1 is often overexpressed, leading to abnormal regulation of cell growth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0f3d327af3e6be902ad275ebf1efb574
https://doi.org/10.31491/apt.2020.06.023
https://doi.org/10.31491/apt.2020.06.023
Publikováno v:
Aging Pathobiology and Therapeutics. 2:32-37
B ackground: Acute myeloid leukemia (AML) is a devastating malignancy with great heterogeneity, novel prognostic biomarkers and therapy targets are needed to improve the precise management of AML patients. Increasing evidence has shown the role of RP
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b128bb89cb314441aebf1e176bb9de16
https://doi.org/10.31491/apt.2020.03.010
https://doi.org/10.31491/apt.2020.03.010
Publikováno v:
New Journal of Chemistry. 44:16913-16920
The Keggin-type polyoxometalate H5PV2Mo10O40 (HPMoV) was encapsulated into the Cu3(BTC)2 framework (H3BTC = 1,3,5-benzenetricarboxylic acid) via a liquid-assisted grinding (LAG) method to obtain nanocrystalline POM@MOF, i.e. NENU-9N, formulated as [C
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5b387c28abd9c851dbc7ab506356c591
https://doi.org/10.1039/d0nj03473h
https://doi.org/10.1039/d0nj03473h